India Weighs Opening Markets to FDA, EU-Approved Drugs

Clinical Trials Advisor
A A
Indian regulators may begin letting some FDA and EU approved drugs onto the Indian market without local Phase III clinical trials.

To View This Article:

Login

Subscribe To Clinical Trials Advisor